Older Adults' Attitudes Towards Stopping Aspirin

University of Michigan

Status: Invitation-only

Conditions: Medication Overuse

Treatments: Other: Less information; Other: Additional harm information

Study type: Interventional

Funder types: Other

Identifiers

NCT07305376

HUM00280646

Details and patient eligibility

About

This online, survey-based experiment will include 2,400 adults who are 65 years and older (n=1,200 each from the United States and Australia). Each participant will be asked to share their opinions on a hypothetical patient scenario developed by our multidisciplinary team. This work is expected to significantly contribute to the understanding of how older adults make decisions about deprescribing medications. The long-term goal is to enhance communication between older adults and clinicians so that medication regimens are optimized and align with care preferences. These results will directly inform future research on the impact of communication choices in clinical practice.

Enrollment: 2,400 estimated patients

Sex: All

Ages: 65+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Reside in Australia or the United States
• 65 years and older

Exclusion criteria

• Unable to read survey written in English

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

2,400 participants in 3 patient groups

Source of recommendation - Physician

Experimental group

Description:

Participants read a hypothetical scenario where a doctor recommends stopping aspirin.

Treatment:

Other: Additional harm information

Other: Less information

Source of recommendation - Pharmacist

Experimental group

Description:

Participants read a hypothetical scenario where a pharmacist recommends stopping aspirin.

Treatment:

Other: Additional harm information

Other: Less information

Source of information - AI

Experimental group

Description:

Participants read a hypothetical scenario where artificial intelligence is used to recommend stopping aspirin.

Treatment:

Other: Additional harm information

Other: Less information